Cognition Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGTX and other ETFs, options, and stocks.

About CGTX

Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions. 

CEO
Lisa R. Ricciardi
CEOLisa R. Ricciardi
Employees
28
Employees28
Headquarters
Purchase, New York
HeadquartersPurchase, New York
Founded
2007
Founded2007
Employees
28
Employees28

CGTX Key Statistics

Market cap
40.41M
Market cap40.41M
Price-Earnings ratio
-0.93
Price-Earnings ratio-0.93
Dividend yield
Dividend yield
Average volume
35.82M
Average volume35.82M
High today
$0.7076
High today$0.7076
Low today
$0.645
Low today$0.645
Open price
$0.689
Open price$0.689
Volume
3.14M
Volume3.14M
52 Week high
$2.54
52 Week high$2.54
52 Week low
$0.2223
52 Week low$0.2223

People also own

Based on the portfolios of people who own CGTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.